Sedative and cardiovascular effects of intranasal or intramuscular dexmedetomidine in healthy dogs

Intranasal dexmedetomidine 0.02 mg kg−1 produced effective sedation with less bradycardia and more profound sedation compared to IM administration in healthy dogs and may be considered as an alternative route for dexmedetomidine administration in dogs.